Cardiovascular Disease
News on molecular diagnostics, pharmacogenomics tests for coronary artery disease, congenital heart defects, and more.
The company is providing its 400-gene test through a physician-involved DTC model akin to Color and Invitae, but with content across a much larger swath of disease and health.
Although there is still demand for the company's COVID-19 products, it has also launched tests for cardiovascular disease, Alzheimer's, and more.
GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana
GeninCode offers a range of tests that combine genetic and clinical data to assess individuals for cardiovascular disease risk including Cardio inCode for heart attack.
The new reports link variants in CYP2C19 to the safety and efficacy of two drugs, a commonly prescribed antiplatelet drug and an antidepressant.
Norwegian Firm CardiNor Raises $1.4M to Develop Cardiovascular Disease ELISA Test
The company said it has demonstrated the potential of secretoneurin to support patient selection for implantable cardioverter defibrillators, among other uses.